vatalanib has been researched along with fluorescein-5-isothiocyanate in 2 studies
| Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (fluorescein-5-isothiocyanate) | Trials (fluorescein-5-isothiocyanate) | Recent Studies (post-2010) (fluorescein-5-isothiocyanate) |
|---|---|---|---|---|---|
| 276 | 42 | 98 | 8,493 | 33 | 2,090 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iijima, M; Nakanishi, T; Sueki, H; Watanabe, H; Yamamoto, A; Yasuhara, H | 1 |
| Dimova, I; Djonov, V; Makanya, AN; Styp-Rekowska, B | 1 |
2 other study(ies) available for vatalanib and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity.
Topics: Animals; Antigens, CD; Cell Migration Inhibition; Dermatitis, Allergic Contact; Dermis; Ear, External; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescein-5-isothiocyanate; Langerhans Cells; Laser-Doppler Flowmetry; Lymph Nodes; Mice; Mice, Inbred BALB C; Oxazolone; Phthalazines; Protein Kinase Inhibitors; Pyridines; Skin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2007 |
Avian area vasculosa and CAM as rapid in vivo pro-angiogenic and antiangiogenic models.
Topics: Amyloid Precursor Protein Secretases; Animals; Bone Marrow Cells; Chick Embryo; Chorioallantoic Membrane; Dextrans; Fluorescein-5-isothiocyanate; Leukocytes, Mononuclear; Male; Mice; Models, Animal; Neovascularization, Physiologic; Phthalazines; Protease Inhibitors; Pyridines; Receptors, Notch; Signal Transduction; Tissue Culture Techniques; Vascular Endothelial Growth Factor A; Yolk Sac | 2015 |